Volume 2.46 | Nov 22

Hematopoiesis News 2.46, November 22, 2011
Hematopoiesis News
     In this issue: Publications | Science News | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Hematopoiesis News on Twitter
TOP STORY
Integrin αvβ3 Regulates Thrombopoietin-Mediated Maintenance of Hematopoietic Stem Cells
Scientists show that a novel adhesion-dependent mechanism via integrin β3 signaling contributes to hematopoietic stem cell maintenance. [Blood] Abstract


Learn More - Reduce Costs Associated With Collecting And Culturing Cells By Using Frozen Primary Cells
PUBLICATIONS (Ranked by Impact Factor of the Journal)
LABORATORY RESEARCH

Low BCR-ABL Expression Levels in Hematopoietic Precursor Cells Enable Persistence of Chronic Myeloid Leukemia Under Imatinib
Researchers have shown, that the number of BCR-ABL positive precursors decreases significantly in all bone marrow compartments during major molecular remission. [Blood] Abstract


Silencing of ETV6/RUNX1 Abrogates PI3K/AKT/mTOR Signaling and Impairs Reconstitution of Leukemia in Xenografts
Scientists suppressed the endogenous ETV6/RUNX1 fusion protein with lentivirally transduced short hairpin RNA in the leukemia cell lines REH and AT-2, and found a distinct reduction of proliferation and cell survival. [Leukemia] Abstract


A Non-Canonical Flt3ITD/ NF-κB Signaling Pathway Represses DAPK1 in Acute Myeloid Leukemia (AML)
A mechanistic basis for epigenetic/transcriptional repression of DAPK1 was investigated in certain forms of AML with poor prognosis, which lacked ER stress-induced apoptosis. [Clin Cancer Res] Abstract


Apigenin Induces Apoptosis in Human Leukemia Cells and Exhibits Anti-Leukemic Activity In Vivo via Inactivation of Akt and Activation of JNK
In this study, researchers investigated the functional role of Akt and JNK signaling cascades in apigenin-induced apoptosis in U937 human leukemia cells and anti-leukemic activity of apigenin in vivo. [Clin Cancer Res] Abstract


Genomic c-Myc Quadruplex DNA Selectively Kills Leukemia
Investigators show that treatment of leukemia with an oligonucleotide encoding the genomic PU27 sequence induces cell cycle arrest and death by oncotic-necrosis due to PU27-mediated suppression of c-myc mRNA/protein expression. [Mol Cancer Ther] Abstract


JmjC-Domain Containing Histone Demethylase 1B-Mediated p15Ink4b Suppression Promotes the Proliferation of Leukemic Progenitor Cells through Modulation of Cell Cycle Progression in Acute Myeloid Leukemia
In this study, scientists investigated the cellular and molecular function of JHDM1B in acute myeloid leukemia cells. [Mol Carcinog] Abstract


The Triterpenoid CDDO-Me Promotes Hematopoietic Progenitor Expansion and Myelopoiesis in Mice
In the current study, researchers observed that CDDO-Me promoted myelopoiesis in both naïve and transplanted mice. [Biol Blood Marrow Transplant] Abstract


Homeostasis of Hematopoietic Stem Cells Regulated by the Myeloproliferative Disease Associated-Gene Product Lnk/Sh2b3 via Bcl-xL
Here, investigators demonstrate that upon stimulation with thrombopoietin, the expression of Bcl-xL was highly enhanced in Lnk-deficient hematopoietic stem cells (HSCs) compared to normal HSCs. [Exp Hematol] Abstract


CLINICAL RESEARCH

Monosomal Karyotype in Adult Acute Myeloid Leukemia: Prognostic Impact and Outcome After Different Treatment Strategies
The objectives of this study is to determine the prognostic impact of monosomal karyotype (MK) in acute myeloid leukemia in the context of the current World Health Organization classification and to evaluate the outcome of MK+ patients after allogeneic hematopoietic stem cell transplantation. [Blood] Abstract


A Genome-Wide Meta-Analysis of Nodular Sclerosis Hodgkin Lymphoma Identifies Risk Loci at 6p21.32
Scientists undertook a genome-wide meta-analysis of 393 European-origin adolescent/young adult nodular sclerosing Hodgkin lymphoma patients and 3,245 controls using the Illumina Human610-Quad Beadchip and Affymetrix Genome-Wide Human SNP Array 6.0. [Blood] Abstract


Try Our New STEMvision App!
SCIENCE NEWS
Lentigen and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer
University Hospitals (UH) Case Medical Center, Case Western Reserve University School of Medicine and Lentigen Corporation announced the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells from the dose limiting toxicity of chemotherapy with Temodar. [University Hospitals] Press Release
INDUSTRY NEWS
Cancer Research UK Launches Nine High-Tech Gene Projects
Unraveling the genetic secrets behind a range of cancers – from understanding how certain genes control cancer to determining how the disease evades treatment – is the aim of a new initiative from Cancer Research UK. [Cancer Research UK] Press Release

RNL Opens the World’s Largest Stem Cell Medical Center in Beijing, China
RNL BIO, South Korea’s premier adult stem cell firm, has just founded the world’s largest stem cell medical center in Beijing, China. [PR Newswire] Press Release
POLICY NEWS
FDA Approves Erwinaze to Treat a Form of Leukemia
The U.S. Food and Drug Administration approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL. [Food and Drug Administration, United States] Press Release


National Institutes of Health (United States)

Food and Drug Administration (United States)
 
Center for Biologics Evaluation and Research (United States)
 
European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
EVENTS
NEW American Association for Cancer Research – Noncoding RNAs and Cancer
January 8-11, 2012
Miami Beach, United States

Visit our events page 
to see a complete list of events in the hematopoietic community
JOB OPPORTUNITIES

Lab Technologist – Tissue Culture (STEMCELL Technologies)

Research and Development Technologist, hPSC Media (STEMCELL Technologies)

Lab Technologist – Pluripotent Stem Cells (STEMCELL Technologies)

Scientist – Pluripotent Stem Cells (STEMCELL Technologies)

Business Analyst – Product Management (STEMSOFT Software)

Postdoctoral Position – Center for Human Genetics (VIB Research Institute)

Postgraduate Students (Masaryk University)

Research Postdoctoral Position (National Taiwan University)

Postdoctoral Fellow – Hematopoietic Stem Cells (City of Hope)

Recruit Top Talent

Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe,
Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Hematopoiesis News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Hematopoiesis Cell News: Archives | Events | Contact Us